Magnetically actuated nanoantennas for wireless glioblastoma therapy
Science Advances · 2026
DOI: 10.1126/sciadv.aeb1237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Monochura Saha und 9 weiteren Autor:innen. Beteiligte Einrichtung: MIT Media Lab, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Wireless Technology. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The ChadTough Defeat DIPG Foundation, The Sontag Foundation Distinguished Scientist Award.
Abstract (Originalsprache)
Glioblastoma (GBM) remains a formidable clinical challenge, characterized by invasive growth, therapeutic resistance, and dismal patient survival. We report the development of HITMAN (highly localized electric field–induced tumor therapy using magnetically actuated nanoantennas), a wireless bioelectric therapy that selectively eradicates GBM cells with cellular precision. Magnetically actuated nanoantennas convert low-frequency (≤200 kHz), deep-brain–penetrant magnetic fields into localized electric fields, thereby triggering protein unfolding, membrane disruption, and ER stress. In vitro, HITMAN demonstrated superior efficacy compared to temozolomide (TMZ), significantly decreasing viability in drug-resistant, patient-derived GBM cells by 52.2%, versus 10% with TMZ while sparing neurons and astrocytes. Mechanistically, HITMAN activated the unfolded protein response and autophagy pathways, suppressed cell cycle and adhesion genes, reduced Ki-67 expression, disrupted cytoskeletal architecture, and elevated p53 levels, underscoring a multifaceted antitumor mechanism. In orthotopic mouse models, HITMAN significantly inhibited tumor growth, extended median survival by more than 50%, and exhibited no systemic toxicity. Thus, HITMAN offers a minimally invasive, spatially precise, and clinically translatable therapy for GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MIT Media Lab, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
ORCID-Profile: Monochura Saha, Baju Joy, Shun-Ying Chen, Preet Patel, Kyuho Jang, Pengrui Zhang, Deblina Sarkar
Förderung
- The ChadTough Defeat DIPG Foundation
- The Sontag Foundation Distinguished Scientist Award
Zitieren
APA
Saha, M., Khan, I. N., Joy, B., Chen, S. Y., Yang, H. T., Patel, P., Jang, K., Zhang, P., Azeemi, F., & Sarkar, D. (2026). Magnetically actuated nanoantennas for wireless glioblastoma therapy. Science Advances. https://doi.org/10.1126/sciadv.aeb1237
Vancouver
Saha M, Khan IN, Joy B, Chen SY, Yang HT, Patel P, et al. Magnetically actuated nanoantennas for wireless glioblastoma therapy. Science Advances. 2026. doi:10.1126/sciadv.aeb1237
BibTeX
@article{Saha2026,
author = {Saha, Monochura and Khan, Ishaq N and Joy, Baju and Chen, Shun-Ying and Yang, Hao-Tung and Patel, Preet and Jang, Kyuho and Zhang, Pengrui and Azeemi, Faheem and Sarkar, Deblina},
title = {Magnetically actuated nanoantennas for wireless glioblastoma therapy},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aeb1237}
}
EUVIMED